{"id":"NCT03869866","sponsor":"Sanofi Pasteur, a Sanofi Company","briefTitle":"Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon","officialTitle":"Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Potential Pilgrims Aged 56 Years and Older","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-04-09","primaryCompletion":"2022-03-18","completion":"2022-03-18","firstPosted":"2019-03-11","resultsPosted":"2025-03-17","lastUpdate":"2025-03-17"},"enrollment":290,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Healthy Volunteers (Meningococcal Infection)"],"interventions":[{"type":"BIOLOGICAL","name":"Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine MenACYW conjugate vaccine","otherNames":["MenQuadfi®"]}],"arms":[{"label":"MenACYW conjugate vaccine","type":"EXPERIMENTAL"}],"summary":"The primary objectives of this study are:\n\n* To describe the antibody response to meningococcal serogroups A, C, W, and Y measured by serum bactericidal assay using baby rabbit complement (rSBA) before and after a single dose of MenACYW conjugate vaccine\n* To describe the antibody response to meningococcal serogroups A, C, W, and Y measured by serum bactericidal assay using human complement (hSBA) before and after a single dose of MenACYW conjugate vaccine\n* To describe the antibody responses against tetanus toxoid at baseline and after a single dose of MenACYW conjugate vaccine\n* To describe the safety profile of a single dose of MenACYW conjugate vaccine","primaryOutcome":{"measure":"Percentage of Participants With Serum Bactericidal Assay Using Baby Rabbit Complement (rSBA) Antibody Titers Greater Than or Equal to (>=) 1:8 Against Meningococcal Serogroups A, C, W, and Y","timeFrame":"Day 30 post-dose","effectByArm":[{"arm":"MenACYW Conjugate Vaccine","deltaMin":90.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"56 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":19},"locations":{"siteCount":3,"countries":["Lebanon","Turkey (Türkiye)"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":288},"commonTop":["Headache","Injection Site Pain","Myalgia","Malaise"]}}